US20100256390A1 - Processes for the preparation of pyrazoles - Google Patents
Processes for the preparation of pyrazoles Download PDFInfo
- Publication number
- US20100256390A1 US20100256390A1 US12/665,738 US66573808A US2010256390A1 US 20100256390 A1 US20100256390 A1 US 20100256390A1 US 66573808 A US66573808 A US 66573808A US 2010256390 A1 US2010256390 A1 US 2010256390A1
- Authority
- US
- United States
- Prior art keywords
- formula
- compound
- hal
- reaction
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims description 25
- 150000003217 pyrazoles Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 135
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 9
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims description 100
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 19
- 239000003054 catalyst Substances 0.000 claims description 18
- 150000002084 enol ethers Chemical class 0.000 claims description 17
- 229910052736 halogen Inorganic materials 0.000 claims description 15
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 claims description 14
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 13
- -1 alkyl propargylate Chemical compound 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 claims description 11
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims description 9
- 229910052794 bromium Inorganic materials 0.000 claims description 9
- 229910052763 palladium Inorganic materials 0.000 claims description 9
- 150000003839 salts Chemical group 0.000 claims description 8
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 7
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 230000002140 halogenating effect Effects 0.000 claims description 3
- 230000003301 hydrolyzing effect Effects 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 0 [1*]C(C)(C)C1=NN(C)C=C1 Chemical compound [1*]C(C)(C)C1=NN(C)C=C1 0.000 description 35
- 239000002585 base Substances 0.000 description 35
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 34
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 30
- 239000002253 acid Substances 0.000 description 29
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- IMBBXSASDSZJSX-UHFFFAOYSA-N 4-Carboxypyrazole Chemical compound OC(=O)C=1C=NNC=1 IMBBXSASDSZJSX-UHFFFAOYSA-N 0.000 description 25
- RLOHOBNEYHBZID-UHFFFAOYSA-N 3-(difluoromethyl)-1-methylpyrazole-4-carboxylic acid Chemical compound CN1C=C(C(O)=O)C(C(F)F)=N1 RLOHOBNEYHBZID-UHFFFAOYSA-N 0.000 description 23
- 239000000047 product Substances 0.000 description 21
- 239000002904 solvent Substances 0.000 description 21
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 20
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- 230000015572 biosynthetic process Effects 0.000 description 20
- 239000000203 mixture Substances 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 14
- 150000002367 halogens Chemical class 0.000 description 14
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 13
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 13
- 238000010626 work up procedure Methods 0.000 description 13
- 238000005160 1H NMR spectroscopy Methods 0.000 description 12
- JIBCIWOQRGOTRD-UHFFFAOYSA-N 3-(dichloromethyl)-1-methylpyrazole Chemical compound CN1C=CC(C(Cl)Cl)=N1 JIBCIWOQRGOTRD-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical group ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 12
- 238000004821 distillation Methods 0.000 description 11
- JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- 150000001450 anions Chemical class 0.000 description 10
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 10
- 238000004817 gas chromatography Methods 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 10
- NNHXBZAWJIBFFE-UHFFFAOYSA-N 3-(difluoromethyl)-1-methylpyrazole-4-carbaldehyde Chemical compound CN1C=C(C=O)C(C(F)F)=N1 NNHXBZAWJIBFFE-UHFFFAOYSA-N 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 239000012442 inert solvent Substances 0.000 description 9
- 230000035484 reaction time Effects 0.000 description 9
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- 239000007983 Tris buffer Substances 0.000 description 8
- 229960004132 diethyl ether Drugs 0.000 description 8
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 239000012299 nitrogen atmosphere Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- 125000005270 trialkylamine group Chemical group 0.000 description 6
- 238000004293 19F NMR spectroscopy Methods 0.000 description 5
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 150000002081 enamines Chemical class 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 4
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 4
- VXYWCTANPTZYGM-UHFFFAOYSA-N 4-bromo-3-(difluoromethyl)-1-methylpyrazole Chemical compound CN1C=C(Br)C(C(F)F)=N1 VXYWCTANPTZYGM-UHFFFAOYSA-N 0.000 description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical group [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 239000012025 fluorinating agent Substances 0.000 description 4
- 238000005658 halogenation reaction Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 150000007522 mineralic acids Chemical class 0.000 description 4
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 238000007127 saponification reaction Methods 0.000 description 4
- 239000012312 sodium hydride Substances 0.000 description 4
- YTZKOQUCBOVLHL-UHFFFAOYSA-N tert-butylbenzene Chemical compound CC(C)(C)C1=CC=CC=C1 YTZKOQUCBOVLHL-UHFFFAOYSA-N 0.000 description 4
- 150000003512 tertiary amines Chemical class 0.000 description 4
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-O triphenylphosphanium Chemical compound C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-O 0.000 description 4
- 238000013022 venting Methods 0.000 description 4
- HFAHNKANSHKECR-UHFFFAOYSA-N 1,1-dichloro-4-ethoxybut-3-en-2-one Chemical compound CCOC=CC(=O)C(Cl)Cl HFAHNKANSHKECR-UHFFFAOYSA-N 0.000 description 3
- JQDCYDWZWBUECX-UHFFFAOYSA-N 3-(difluoromethyl)-1-methylpyrazole Chemical compound CN1C=CC(C(F)F)=N1 JQDCYDWZWBUECX-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- ABFCPDYYBWSWKZ-UHFFFAOYSA-N CC1=CN(C)N=C1C(F)F Chemical compound CC1=CN(C)N=C1C(F)F ABFCPDYYBWSWKZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 235000019502 Orange oil Nutrition 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- FBCCMZVIWNDFMO-UHFFFAOYSA-N dichloroacetyl chloride Chemical compound ClC(Cl)C(Cl)=O FBCCMZVIWNDFMO-UHFFFAOYSA-N 0.000 description 3
- 230000026030 halogenation Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 3
- 150000004679 hydroxides Chemical class 0.000 description 3
- 150000007529 inorganic bases Chemical class 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000010502 orange oil Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- FZNKJQNEJGXCJH-UHFFFAOYSA-N 1-methyl-3-(trifluoromethyl)pyrazole-4-carboxylic acid Chemical compound CN1C=C(C(O)=O)C(C(F)(F)F)=N1 FZNKJQNEJGXCJH-UHFFFAOYSA-N 0.000 description 2
- IQJWMVAKDMUUFG-UHFFFAOYSA-N 3-(dichloromethyl)-1-methylpyrazole-4-carboxylic acid Chemical compound CN1C=C(C(O)=O)C(C(Cl)Cl)=N1 IQJWMVAKDMUUFG-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- LDAKXYUZJBXSRB-UHFFFAOYSA-N C.CN1C=CC(C(Cl)Cl)=N1 Chemical compound C.CN1C=CC(C(Cl)Cl)=N1 LDAKXYUZJBXSRB-UHFFFAOYSA-N 0.000 description 2
- VLENBCSIGCAXLL-UHFFFAOYSA-N C.CN1C=CC(C(F)F)=N1 Chemical compound C.CN1C=CC(C(F)F)=N1 VLENBCSIGCAXLL-UHFFFAOYSA-N 0.000 description 2
- FNIHWXJHLZZRBC-UHFFFAOYSA-I CN1C=CC(C(Cl)Cl)=N1.CN1C=CC(C(F)F)=N1.I[V](I)I.I[V]I Chemical compound CN1C=CC(C(Cl)Cl)=N1.CN1C=CC(C(F)F)=N1.I[V](I)I.I[V]I FNIHWXJHLZZRBC-UHFFFAOYSA-I 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000009172 bursting Effects 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 230000006315 carbonylation Effects 0.000 description 2
- 238000005810 carbonylation reaction Methods 0.000 description 2
- 239000003518 caustics Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- VRLDVERQJMEPIF-UHFFFAOYSA-N dbdmh Chemical compound CC1(C)N(Br)C(=O)N(Br)C1=O VRLDVERQJMEPIF-UHFFFAOYSA-N 0.000 description 2
- ZJULYDCRWUEPTK-UHFFFAOYSA-N dichloromethyl Chemical compound Cl[CH]Cl ZJULYDCRWUEPTK-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000003682 fluorination reaction Methods 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004678 hydrides Chemical class 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 2
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- CSSYKHYGURSRAZ-UHFFFAOYSA-N methyl 2,2-difluoroacetate Chemical compound COC(=O)C(F)F CSSYKHYGURSRAZ-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- OEOFQABUOAWYMP-UHFFFAOYSA-N oxiren-2-ol Chemical compound OC1=CO1 OEOFQABUOAWYMP-UHFFFAOYSA-N 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- PKVRJCUKSNFIBN-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 PKVRJCUKSNFIBN-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- ACVWHDUFQJHVRR-UHFFFAOYSA-N 4-bromo-3-(dichloromethyl)-1-methylpyrazole Chemical compound CN1C=C(Br)C(C(Cl)Cl)=N1 ACVWHDUFQJHVRR-UHFFFAOYSA-N 0.000 description 1
- QAGMEJXKXVRHLP-UHFFFAOYSA-N 4-bromo-3-(fluoromethyl)-1-methylpyrazole Chemical compound CN1C=C(Br)C(CF)=N1 QAGMEJXKXVRHLP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229910014263 BrF3 Inorganic materials 0.000 description 1
- ZUTGHYSEBBABEK-UHFFFAOYSA-N C#CC(=O)OCC.[H]C(F)(F)C(=O)NNC.[H]C(F)(F)C1=NN(C)C=C1C(=O)OCC Chemical compound C#CC(=O)OCC.[H]C(F)(F)C(=O)NNC.[H]C(F)(F)C1=NN(C)C=C1C(=O)OCC ZUTGHYSEBBABEK-UHFFFAOYSA-N 0.000 description 1
- ICVMLSGZGVLYLY-UHFFFAOYSA-N C.C.C.CCOC(=O)C1=CN(C)N=C1C(F)F.CN1C=C(Br)C(C(F)F)=N1 Chemical compound C.C.C.CCOC(=O)C1=CN(C)N=C1C(F)F.CN1C=C(Br)C(C(F)F)=N1 ICVMLSGZGVLYLY-UHFFFAOYSA-N 0.000 description 1
- NHUNKTWDCYHRPB-UHFFFAOYSA-N C.C.C.CN1C=C(Br)C(C(F)F)=N1.[H]OC(=O)C1=CN(C)N=C1C(F)F Chemical compound C.C.C.CN1C=C(Br)C(C(F)F)=N1.[H]OC(=O)C1=CN(C)N=C1C(F)F NHUNKTWDCYHRPB-UHFFFAOYSA-N 0.000 description 1
- FNMNBAOSJTYDML-UHFFFAOYSA-K C.CN1C=C(Br)C(C(F)F)=N1.CN1C=CC(C(F)F)=N1.ClC(Cl)(Cl)Cl.I[V](I)I Chemical compound C.CN1C=C(Br)C(C(F)F)=N1.CN1C=CC(C(F)F)=N1.ClC(Cl)(Cl)Cl.I[V](I)I FNMNBAOSJTYDML-UHFFFAOYSA-K 0.000 description 1
- HNWYYWQJDPMPEV-UHFFFAOYSA-N C=COCC.CCOC=CC(=O)C(Cl)Cl.O=C(Cl)C(Cl)Cl Chemical compound C=COCC.CCOC=CC(=O)C(Cl)Cl.O=C(Cl)C(Cl)Cl HNWYYWQJDPMPEV-UHFFFAOYSA-N 0.000 description 1
- 125000006416 CBr Chemical group BrC* 0.000 description 1
- OSQVURMBGDFTAB-UHFFFAOYSA-L CCOC=CC(=O)C(Cl)Cl.CN1C=CC(C(Cl)Cl)=N1.CNN.I[V]I Chemical compound CCOC=CC(=O)C(Cl)Cl.CN1C=CC(C(Cl)Cl)=N1.CNN.I[V]I OSQVURMBGDFTAB-UHFFFAOYSA-L 0.000 description 1
- FYXQVUSUDRLTQR-KNHVMYODSA-N CN.[H]C(F)(F)C(=O)/C(=C/OCC)C(=O)OCC.[H]C(F)(F)C(=O)/C(=C\NC)C(=O)OCC Chemical compound CN.[H]C(F)(F)C(=O)/C(=C/OCC)C(=O)OCC.[H]C(F)(F)C(=O)/C(=C\NC)C(=O)OCC FYXQVUSUDRLTQR-KNHVMYODSA-N 0.000 description 1
- ZOVWSNJIMLVDFK-UHFFFAOYSA-N CN1C=C(Br)C(C(Cl)Cl)=N1.CN1C=C(Br)C(C(F)F)=N1 Chemical compound CN1C=C(Br)C(C(Cl)Cl)=N1.CN1C=C(Br)C(C(F)F)=N1 ZOVWSNJIMLVDFK-UHFFFAOYSA-N 0.000 description 1
- HWQLEFJLLHPQMD-UHFFFAOYSA-N CNN.[H]C(F)(F)C(=O)NNC.[H]C(F)(F)C(=O)OC Chemical compound CNN.[H]C(F)(F)C(=O)NNC.[H]C(F)(F)C(=O)OC HWQLEFJLLHPQMD-UHFFFAOYSA-N 0.000 description 1
- IEFVHILYNZOXTK-UHFFFAOYSA-N COC(=O)C(F)F.NN.[H]N(C)N([H])C(=O)C(F)F.[H]N([H])N([H])C(=O)C(F)F Chemical compound COC(=O)C(F)F.NN.[H]N(C)N([H])C(=O)C(F)F.[H]N([H])N([H])C(=O)C(F)F IEFVHILYNZOXTK-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 238000000023 Kugelrohr distillation Methods 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 229910000792 Monel Inorganic materials 0.000 description 1
- IMLVPEQZRVHYGC-JRPWWIQBSA-N N.NCl.[H]C(F)(F)C(=O)/C(=C\N(C)N)C(=O)OCC.[H]C(F)(F)C(=O)/C(=C\NC)C(=O)OCC.[H]C(F)(F)C1=NN(C)C=C1C(=O)OCC.[Na]OCl Chemical compound N.NCl.[H]C(F)(F)C(=O)/C(=C\N(C)N)C(=O)OCC.[H]C(F)(F)C(=O)/C(=C\NC)C(=O)OCC.[H]C(F)(F)C1=NN(C)C=C1C(=O)OCC.[Na]OCl IMLVPEQZRVHYGC-JRPWWIQBSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- GUNJVIDCYZYFGV-UHFFFAOYSA-K antimony trifluoride Chemical compound F[Sb](F)F GUNJVIDCYZYFGV-UHFFFAOYSA-K 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- FMSYTQMJOCCCQS-UHFFFAOYSA-L difluoromercury Chemical compound F[Hg]F FMSYTQMJOCCCQS-UHFFFAOYSA-L 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- FMVJYQGSRWVMQV-UHFFFAOYSA-N ethyl propiolate Chemical compound CCOC(=O)C#C FMVJYQGSRWVMQV-UHFFFAOYSA-N 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 229910000856 hastalloy Inorganic materials 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- IKGLACJFEHSFNN-UHFFFAOYSA-N hydron;triethylazanium;trifluoride Chemical compound F.F.F.CCN(CC)CC IKGLACJFEHSFNN-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002506 iron compounds Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical group [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- UORVCLMRJXCDCP-UHFFFAOYSA-N propynoic acid Chemical compound OC(=O)C#C UORVCLMRJXCDCP-UHFFFAOYSA-N 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 238000000526 short-path distillation Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- FQFKTKUFHWNTBN-UHFFFAOYSA-N trifluoro-$l^{3}-bromane Chemical compound FBr(F)F FQFKTKUFHWNTBN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
- C07C251/74—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C251/76—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Definitions
- the present invention relates to novel processes for the production of 3-halomethyl-1-methyl-1H-pyrazoles, which are useful as intermediates in the production of fungicides.
- 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid and 3-trifluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid are valuable intermediates in the preparation of pyrazolyl carboxanilide fungicides, as described, for example, in WO 03/070705 and WO 03/074491.
- the aim of the present invention is therefore to provide novel processes for the production of key intermediates in the synthesis of 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid and 3-trifluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid that makes it possible to prepare said acids with high regioselectivity (in respect to the two nitrogen atoms of the pyrazole ring), in high yields and good quality in an economically advantageous and easily handled way.
- the invention relates to a process for the preparation of a compound of formula (I)
- Hal and Hal′ are independently Cl or F, and R 1 is H, Cl or F, comprising the steps of
- R 2 is C1-6 alkyl
- Hal, Hal′ and R 1 are as defined above, and
- the invention provides a process for the preparation of a compound of formula (VI)
- Hal, Hal′ and R 1 are as defined above and R 3 is selected from H and C1-6 alkyl comprising reacting a hydrazide of formula (XXIII)
- Hal, Hal′ and R 1 are as defined above,
- R3 is as defined above.
- the invention provides a process for the preparation of a compound of formula (VI)
- Hal, Hal′ and R 1 are as defined above and R 3 is selected from H and C1-6 alkyl comprising reacting a compound of formula (XXV)
- Hal, Hal′, R 1 and R 3 are as defined above with chloramine.
- the invention relates to a compound of formula X
- the invention relates to a compound of formula VIII
- the invention relates to a compound of formula VII
- step i) of the reaction according to a first embodiment of the invention a compound of formula (II) reacts with an enol ether of formula (III) to give a 4-alkoxy-3-en-2-one of formula (IV) (Scheme 1)
- leaving group refers to a moiety that can be displaced by enol ether (III) to form a carbon-carbon bond present in compound (IV).
- Preferred leaving groups are halogens. A more preferred leaving group is chlorine.
- R 2 is ethyl
- reaction of compound (II) with the enol ether (III) may take place in a suitable solvent. Alternatively, and preferably, the reaction takes place in the absence of a solvent.
- Preferred solvents are toluene, hexane, dichloromethane and diethylether.
- the reaction is conducted under an inert atmosphere. More preferably, the reaction is conducted under a nitrogen atmosphere. Preferably, the reaction proceeds with purge to help remove volatile co-products.
- the reaction takes place in the presence of a base.
- bases are pyridine, alkyl pyridines or trialkylamines.
- the reaction occurs in the absence of base.
- the enol ether (III) is present in excess relative to the compound (II). More preferably, the enol ether is present in an amount of between 1.1 and 10 equivalents relative to the amount of compound (II) on a molar basis. More preferably, the enol ether is present in an amount of between 1.2 and 5 equivalents relative to the amount of compound (II) on a molar basis. More preferably, the enol ether is present in an amount of between 1.5 and 2.5 equivalents relative to the amount of compound (II) on a molar basis. More preferably, the enol ether is present in an amount of about 2 equivalents relative to the amount of compound (II) on a molar basis.
- the enol ether (III) is added to the compound (II). More preferably, the enol ether (III) is added to the compound (II) over at least 1 hour. More preferably, the enol ether (III) is added to the compound (II) over at least 4 hours. More preferably, the enol ether (III) is added to the compound (II) over about 8 hours.
- the reaction is cooled during the addition of the enol ether (III) to the compound (II).
- the reaction is cooled to between ⁇ 20 and ⁇ 40° C. during the addition of the enol ether (III) to the compound (II).
- the reaction is allowed to continue for at least 1 hour. More preferably, the reaction is allowed to continue for at least 6 hours. More preferably, the reaction is allowed to continue for at least 8 hours.
- reaction mixture may be necessary or desirable to isolate the 4-alkoxy-3-en-2-one of formula (IV), if isolation is intended. Suitable work up procedures are described for example in Experimental Organic Chemistry standard and microscale (2 nd Edition ), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999.
- step ii) of the reaction according to a first embodiment of the invention a 4-alkoxy-3-en-2-one of formula (IV) reacts with methyl hydrazine to give a 3-halomethyl-1-methyl-1H-pyrazole (I) (Scheme 2).
- reaction of compound (IV) with methyl hydrazine preferably takes place in a suitable solvent. Alternatively the reaction takes place in the absence of a solvent.
- Preferred solvents are xylene, toluene, mesitylene, tert-butyl benzene, chlorobenzene, 1,2-dichlorobenzene, tetrahydrofuran, diethyl ether and hexane.
- a more preferred solvent is tetrahydrofuran.
- methyl hydrazine is used in an amount of 0.7 to 1.3 equivalents relative to the amount of 4-alkoxy-3-en-2-one of formula (IV).
- the methyl hydrazine is added to the 4-alkoxy-3-en-2-one of formula (IV).
- both the methyl hydrazine and the 4-alkoxy-3-en-2-one of formula (IV) are both dissolved in solvent. Addition preferably takes place over a period of between 5 minutes and 10 hours, more preferably over about 5 hours.
- the reaction is preferably held at between 0 to 50° C., more preferably at between 35 to 45° C.
- reaction mixture may be necessary or desirable to isolate the pyrazole (I), if isolation is intended. Suitable work up procedures are described for example in Experimental Organic Chemistry standard and microscale (2 nd Edition ), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999.
- Suitable techniques include recrystallization, distillation, and chromatography.
- pyrazole (I) is subjected to a halogenation step to convert it to 4-halopyrazole of formula (V) (Scheme 3)
- the halogenation reaction is conducted in a solvent.
- a preferred solvent is carbon tetrachloride.
- the reaction is conducted under an inert atmosphere. More preferably, the reaction is conducted under a nitrogen atmosphere. Preferably, the reaction proceeds with purge to help remove volatile co-products.
- X is Br.
- a preferred halogenating agents are elemental bromine (Br 2 ), N-bromosuccinimide and 1,3-dibromo-5,5-dimethylhydantoin. More preferably, the halogenating agent is Br 2 in the presence of an iron compound, preferably iron powder.
- the halogentating agent is used in excess relative to pyrazole (I). More preferably, the halogentating agent is used in amount of 1.5 to 5 equivalents relative to pyrazole (I) on a molar basis.
- the reaction is allowed to continue for at least 1 hour. More preferably, the reaction is allowed to continue for from 1 to 48 hours. More preferably, the reaction is allowed to continue for from 1 to 5 hours.
- 4-halopyrazole (V) is subjected to a carbonylation step to convert it to 4-carboxypyrazole of formula (VI) (Scheme 4)
- R 3 is H or C1-6 alkyl.
- R 3 is Ethyl or H.
- Reagent R 3 OH is preferably present in excess relative to 4-halopyrazole (V), preferably in an amount of from 100 to 150 equivalents relative to the amount of (V) on a molar basis.
- Carbon monoxide is preferably used in excess relative to the amount of (V).
- the reaction takes place in the presence of a palladium catalyst.
- the palladium catalyst is preferably a palladium (II) or palladium (0) catalyst.
- Preferred catalysts are tris(triphenylphosphine) palladium (II) chloride, bis(triphenylphosphine) palladium (II) chloride, and tetrakis(triphenylphosphine)palladium(0).
- a preferred catalyst is tris(triphenylphosphine) palladium (II) chloride.
- the palladium catalyst is used in an amount of between 0.01 and 0.5 equivalents relative to the amount of 4-halopyrazole (V), more preferably between 0.1 and 0.3 equivalents.
- triphenylphosphine is added to the reaction, preferably in an amount of 0.5 to 0.7 equivalents.
- the reaction is conducted at a temperature of from 50 to 200° C., more preferably at a temperature of from 100 to 150° C.
- bases are nitrogen-containing organic bases, preferably tertiary amines, more preferably trialkylamines, preferably trimethylamine, triethylamine, diisopropylethylamine (Hünig's Base), or tri-n-butylamine.
- Alternative preferred bases are N,N-dimethylaniline or N-methylmorpholine, piperidine, pyrrolidine, alkali metal or alkaline earth metal alcoholates, preferably lithium, sodium or potassium alcoholates, preferably methanolates, ethanolates or butanolates, or inorganic bases, preferably hydroxides, more preferably NaOH or KOH, or hydrides, preferably NaH.
- tertiary amines preferably trialkylamines, more preferably trimethylamine, triethylamine, diisopropylethylamine (Hünig's Base), or tri-n-butylamine.
- Triethylamine is very highly preferred.
- Suitable amounts of base for that reaction are, for example, from 1 to 10 equivalents, especially from 4 to 6 equivalents.
- the reaction time is generally from 1 to 48 hours, preferably from 1 to 36 hours, more preferably 1 to 18 hours.
- the reaction according to the invention is carried out typically at elevated pressure, preferably 1 to 20 bar, more preferably 10 to 15 bar.
- an optional further step comprises hydrolyzing the group R 3 to a compound (VI) wherein R 3 is hydrogen, or a salt form thereof (Scheme 5).
- R 3 is C1-6 alkyl
- Hydrolysis can be effected under either acid or basic conditions. If basic conditions are employed, generally a salt form of 4-carboxypyrazole (VI) is obtained. A further step of acidification to convert the salt to the free acid may be employed.
- Preferred bases for the hydrolysis reaction are metal hydroxides and metal carbonates. More preferred bases are alkali metal hydroxides. Still more preferred are sodium, potassium and lithium hydroxide. Most preferred is sodium hydroxide.
- the base is used in excess relative to 4-carboxypyrazole (VI). More preferably, between 1 and 5 equivalents of base are used. Still more preferably, between 1 and 3 equivalents of base are used.
- water is present in excess.
- a co-solvent is present.
- a preferred co-solvent is ethanol.
- the hydrolysis preferably takes place at between 0 and 200° C., more preferably at between 50 and 150° C.
- the free acid (VI) may be liberated by treatment with acid.
- Preferred acids are mineral acids, preferably hydrochloric or sulphuric acid. Most preferred is hydrochloric acid.
- mineral acids or organic acids may be used. Preferred are mineral acids. More preferred are hydrochloric and sulphuric acid. Most preferred is hydrochloric acid.
- At least 0.01 equivalents of acid relative to the amount of (VI) on a molar basis are employed, more preferably between 0.01 and 5 equivalents, still more preferably 1 to 5 equivalents.
- acid hydrolysis occurs at a temperature of between 40 and 100° C.
- the reaction sequence includes a halogen exchange step.
- halogen exchange refers to a reaction wherein halogen atoms of one element are exchanged for halogen atoms of a second, different element.
- chlorine atoms are exchanged for fluorine atoms.
- Halogen exchange may be conducted at any suitable step of the reaction sequence.
- halogen exchange is effected on 3-dichloromethyl-1-methyl-1H-pyrazole (VII) to give 3-difluoromethyl-1-methyl-1H-pyrazole-4-carbaldehyde (VIII) (Scheme 6).
- halogen exchange is effected on 4-bromo-3-dichloromethyl-1-methyl-1H-pyrazole (IX) to give 4-bromo-3-fluoromethyl-1-methyl-1H -pyrazole (X) (Scheme 7).
- halogen exchange is effected on 3-dichloromethyl-1-methyl-1H-pyrazole-4-carboxylate (XI) or a salt form thereof to give 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylate (XII) (Scheme 8).
- Halogen exchange may be conducted under a variety of conditions. Preferably, halogen exchange is conducted in the presence of a source of F ⁇ ions.
- Preferred reagents are AgF, KF, HgF 2 , Bu 4 N + HF 2 ⁇ , BrF 3 , Et 3 N.2HF, Et 3 N.3HF and HF plus SbF 3 .
- a very highly preferred reagent is Et 3 N.3HF.
- the halogen exchange reaction is optionally conducted in a solvent. Alternatively, and preferably, the reaction is conducted under solvent-free conditions.
- the reaction is held at between 0 and 250° C. More preferably, the reaction is held at between 50 and 200° C. More preferably, the reaction is held at between 125 and 175° C. Most preferably, the reaction is held at about 150° C.
- Suitable techniques include recrystallization, distillation, and chromatography.
- the reaction takes place in a solvent.
- Dimethylformamide is preferred.
- the reaction occurs under acid catalysis.
- p-Toluene sulphonic acid is preferred.
- 4-carboxypyrazole (VI) may be hydrolysed to the free acid or a salt form thereof as outlined above.
- the enamine (XXV) is reacted with a base prior to reaction with chloramine.
- a preferred base is sodium hydride.
- the reaction takes place in a solvent.
- solvents are diethyl ether, tetrahydrofuran and mixtures thereof.
- 4-carboxypyrazole (VI) may be hydrolysed to the free acid or a salt form thereof as outlined above.
- Hal, Hal′ and R 1 are all fluorine.
- Hal and Hal′ are fluorine and R 1 is hydrogen.
- Hal and Hal′ are both chlorine, and R 1 is hydrogen.
- the present invention relates to a process for the production of a compound of formula XIII
- R 1 is C 1 -C 6 alkyl, to form a compound of formula XV
- R 1 is as defined above;
- R 2 is C 1 -C 6 alkyl
- single compounds of formula (III), such as compounds of formula (III), wherein R 1 is ethyl, can be used or mixtures thereof.
- An example of such a mixture are compounds of formula (III), wherein in R 1 is methyl, mixed with compounds of formula (III), wherein R 1 is ethyl.
- R 1 is ethyl.
- the reaction according to the invention is preferably carried out in a temperature range of from ⁇ 40° C. to 0° C., especially from ⁇ 40° C. to ⁇ 20° C.
- the reaction can be carried out in the presence or absence of a base.
- bases include pyridine, alkyl pyridines or trialkylamines.
- the reaction can be carried out without solvent or in an inert solvent.
- Preferred inert solvents are, for example, toluene, hexane, dichloromethane or diethylether.
- the reaction is carried out without a solvent.
- the compound of formula (III) for example ethylenol ether
- the compound of formula (III) can be used in equimolar amounts, in sub-equimolar amounts or in excess relative to compounds of formula XIV, preferably the compound of formula (III) is used in excess, more preferably in an 1.5-fold to 3-fold excess.
- the reaction according to the invention may be carried out in a dry inert gas atmosphere.
- nitrogen can be used as inert gas.
- the reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours.
- the reaction according to the invention can be carried out at normal, elevated or reduced pressure. In one embodiment of the invention the reaction is carried out at normal pressure.
- the reaction according to the invention is preferably carried out in a temperature range of from 0° C. to 50° C., especially from 10° C. to 25° C.
- the reaction is conveniently carried out in an inert solvent.
- inert solvents are, for example, xylene, toluene, mesitylene, tert-butyl benzene, chlorobenzene, 1,2-dichlorobenzene, tetrahydrofuran, diethyl ether and hexane, preferably tetrahydrofuran.
- methylhydrazine in the reaction according to the invention, can be used in equimolar amounts, in sub-equimolar amounts or in excess relative to compounds of formula XV, preferably methylhydrazine is used in equimolar amounts.
- the reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours, more preferably 1 to 5 hours.
- the reaction according to the invention can be carried out at normal, elevated or reduced pressure. In one embodiment of the invention the reaction is carried out at normal pressure.
- the fluorination according to the invention is preferably carried out in a temperature range of from 100° C. to 200° C., especially from 140° C. to 160° C.
- the preferred fluorinating agent is tris(hydrogen fluoride)-triethylamine.
- the fluorinating agent is typically used in excess relative to compounds of formula VII, preferably in a 2-fold to 5-fold excess.
- the fluorination can be carried out without solvent or in an inert solvent.
- Preferred inert solvents are, for example, acetonitrile, chloroform, carbon tetrachloride and dichloromethane. Use of excess tris(hydrogen fluoride)-triethylamine, which then acts as solvent is preferred.
- the reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours, more preferably 1 to 5 hours.
- the reaction according to the invention can be carried out at normal, elevated or reduced pressure. In one embodiment of the invention the reaction is carried out at elevated pressure.
- the bromination according to the invention is preferably carried out in a temperature range of from 0° C. to 100° C., preferably from 20° C. to 40° C.
- reaction is conveniently carried out in an inert solvent.
- a preferred inert solvent is, for example, carbon tetrachloride.
- Preferred brominating agents are, for example, bromine in the presence of an iron catalyst, N-bromosuccinimide and 1,3-dibromo-5,5-dimethylhydantoin; preferably bromine in the presence of an iron catalyst.
- brominating agent is bromine in the presence of an iron catalyst
- said bromine is typically used in excess relative to compounds of formula VIII, preferably in a 1.5-fold to 5-fold excess; and said iron catalyst is used typically in the form of iron powder and in the range of from 0.1 to 1 equivalents relative to compounds of formula VIII, especially from 0.3 to 0.8 equivalents.
- the reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours, more preferably 1 to 5 hours.
- the reaction according to the invention can be carried out at normal, elevated or reduced pressure. In one embodiment of the invention the reaction is carried out at normal pressure.
- the preferred C 1 -C 6 alkanol is ethanol; but also mixtures C 1 -C 6 alkanols can be used, such as a mixture of methanol/ethanol.
- the reaction according to the invention is preferably carried out in a temperature range of from 50° C. to 200° C., especially from 100° C. to 150° C.
- the reaction is conveniently carried out in a large excess of the C 1 -C 6 alkanol, such as a 100-fold to 150-fold excess, which then acts as solvent.
- a large excess of the C 1 -C 6 alkanol such as a 100-fold to 150-fold excess, which then acts as solvent.
- ethanol is used.
- a large excess of carbon monoxide is used.
- a suitable palladium catalyst is tris(triphenylphosphonium)palladium(II)chloride.
- Said palladium catalyst is used generally in the range of from 0.1 to 0.5 equivalents relative to compounds of formula X, especially from 0.1 to 0.3 equivalents. If tris(triphenylphosphonium)palladium(II)chloride is used as palladium catalyst, then generally triphenyl phosphine is also added to the reaction mixture in amounts of from 0.5 to 0.7 equivalents relative to compounds of formula X.
- Suitable bases are, for example, nitrogen-containing organic bases, such as, for example, tertiary amines, such as trialkylamines, e.g. trimethylamine, triethylamine, diisopropylethylamine (Hünig's Base), or tri-n-butylamine, N,N-dimethylaniline or N-methylmorpholine, piperidine, pyrrolidine, alkali metal or alkaline earth metal alcoholates, such as, for example, lithium, sodium or potassium alcoholates, especially methanolates, ethanolates or butanolates, or inorganic bases, such as hydroxides, e.g.
- Bases to which preference is given are tertiary amines, such as trialkylamines, e.g. trimethylamine, triethylamine, diisopropylethylamine (Hünig's Base), or tri-n-butylamine, especially triethylamine.
- Suitable amounts of base for that reaction are, for example, from 1 to 10 equivalents, especially from 4 to 6 equivalents.
- the reaction time is generally from 1 to 48 hours, preferably from 1 to 36 hours, more preferably 1 to 18 hours.
- the reaction according to the invention is carried out typically at elevated pressure, such as 1 to 20 bar, preferably 10 to 15 bar.
- Process step b6) the saponification of compounds of formula (XII) to form the compound of formula (XIII), can be carried out as described under step b6.1) (alkaline saponification) or under step b6.2) (acidic saponification).
- Step b6.1) can be divided into two sub-steps: i) the formation of the anion of the compound of formula (XIII) (“the anion”) by adding a base and ii) the formation of the compound of formula (I) (“the free acid”) by later adding an acid.
- hydroxide base is used to form the anion, then NaOH or KOH, especially NaOH, is preferred.
- a suitable amount of hydroxide base is, for example, at least one equivalent relative to compounds of formula (XII), preferably from 1 to 5 equivalents; more preferably from 1 to 3 equivalents.
- inorganic bases such as hydroxides, for example LiOH, NaOH or KOH, or carbonates, for example sodium carbonate, are preferred.
- hydroxides for example LiOH, NaOH or KOH
- carbonates for example sodium carbonate
- at least one equivalent of water and at least one equivalent of the base relative to compounds of formula (XII) are used.
- the formation of the anion can be carried out in an inert solvent, such as ethanol.
- the formation of the anion is preferably carried out in a temperature range of from 0° C. to 200° C.
- the reaction time for anion formation is generally from 1 to 48 hours, preferably from 1 to 18 hours.
- Said anion formation can be carried out at normal, elevated or reduced pressure, preferably at normal pressure.
- Suitable acids are inorganic acids, such as hydrochloric acid or sulfuric acid; or organic acids, such as formic acid, acetic acid or propionic acid. Preference is given to inorganic acids and special preference is given to hydrochloric acid.
- the acid is added in a temperature range of from 50° C. to 95° C.
- the reaction time for formation of the free acid is generally from 1 to 48 hours, preferably from 1 to 18 hours.
- Said free acid formation can be carried out at normal, elevated or reduced pressure, preferably at normal pressure.
- the acid used in step b6.2) is typically an inorganic acid, such as hydrochloric acid or sulfuric acid; or an organic acid, such as formic acid, acetic acid or propionic acid.
- aqueous solutions of the acid are used in step b6.2).
- a preferable amount of water is at least one equivalent relative to compounds of formula (XII).
- a preferable amount of acid is at least 0.01 equivalents relative to compounds of formula (XII), more preferably from 0.01 to 5 equivalents; even more preferably from 1 to 5 equivalents.
- the formation of the free acid is preferably carried out in a temperature range of from 40° C. to 100° C.
- the reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours.
- Said free acid formation can be carried out at normal, elevated or reduced pressure, preferably at normal pressure.
- the second embodiment of the present invention makes it possible to produce compounds of formula I in a high yield, with a high degree of regioselectivity and at low cost.
- the compounds of formula (X), (VII) and (VIII) are valuable intermediates for the preparation of compounds of formula (XIII) and were developed specifically for the present process according to the invention.
- the present invention accordingly relates also to those compounds.
- steps b1), b2), b3), b4) and b5) are performed as described above.
- R 1 and R 2 stands for C 1 -C 6 alkyl and TREAT HF means tris(hydrogen fluoride)-triethylamine.
- the invention includes, in separate embodiments, the following multi-step processes, which involve:
- Dichloroacetyl chloride (114.9 g, compound of formula XIV) was charged to a clean/oven dried 250 ml 3-necked flask fitted with nitrogen feed, syringe feed, thermometer and a PTFE coated magnetic stirrer.
- the reactor was vented via a cold finger condenser and water condenser to follow.
- a caustic scrubber system was connected to the vent from the water condenser system.
- the agitation was provided by a magnetic stirrer/hotplate fitted with a drykold acetone bath.
- the cold finger condenser was filled with the same cooling mixture.
- the reactor contents were agitated and the contents cooled to ⁇ 40° C. with a gentle nitrogen purge applied to the reactor.
- 1,1-Dichloro-4-ethoxy-but-3-en-2-one (0.99 g, compound of formula XVI) was dissolved in tetrahydrofuran (12.5 ml) in a clean/dry 50 ml 3-necked flask fitted with thermometer, condenser and syringe feed system. The top of the condenser was back pressured with a gentle flow of nitrogen. The reactor contents were agitated and heated to 40° C. then the N-methyl hydrazine (0.26 g) was dissolved in tetrahydrofuran (25 ml) and the resultant solution syringe pump fed into the reactor over a 5 hour period. The reaction mixture was agitated overnight under nitrogen to complete.
- Formaldehyde (7.4 g) was charged to the reactor and the mixture agitated for 30 minutes at room temperature accompanied by a small exotherm reaction. 1 g Pt/C was added and washed in with methanol (20 ml). The Parr reactor was sealed, purged with nitrogen three times, purged with hydrogen three times (all to 200 psi) and then pressurized up to 200 psi with hydrogen. Agitation and external heating were applied to heat the reaction to 50° C. The reactor was held under these conditions for 3 h and then allowed to cool. The system was purged three times with nitrogen to 200 psi. The contents were removed and filtered. The solvent was removed under vacuum, filtered and concentrated under vacuo. The compound of formula XX was obtained in the form of an orange oil (9.1 g). Yield 40% total isomers and 36% of the desired isomer. The product was analysed by GC, GCMS and NMR ( 1 H and 19 F).
- a 25 ml reaction tube was fitted with a magnetic stirrer, thermometer, condenser and nitrogen atmosphere.
- Dimethylformamide (10 g), ethyl propargylate (0.14 g), the compound of formula XX (0.24 g) and p-toluene sulphonic acid (0.028 g) were charged to the reaction tube.
- the mixture was stirred at 50° C. overnight, 80° C. overnight and then 110° C. overnight to give the desired product (compound of formula XVII).
- the compound of formula (I) can be formed from the compound of formula (V) via step b6) as described above.
- the compound of formula (XVII) can be formed from the compound of formula (XX) via the methology described in comparative example C5 above.
- the compound of formula (XII) can be formed from the compound of formula (XVII) via step b6) as described above.
- a 100 ml conical flask was fitted with a magnetic stirrer and thermometer. Diethyl ether (31 ml) and ammonium chloride (0.91 g) were charged to the flask. The mixture was cooled to ⁇ 10° C. and aqueous ammonia solution (1.7 g) was added. Sodium hypochlorite (14.3 g) solution was charged over 10 minutes to the vigorously stirred solution at ⁇ 10° C., and the reaction was then stirred at ⁇ 10° C. for 0.5 hr. The organic layer was separated, washed with brine, dried over CaCl 2 for 1 hr at ⁇ 15° C. The desired chloramine was generated as a 3% chloramine solution in diethylether.
- This tetrahydrofuran solution was added slowly to the chloramine/diethylether-solution described above (6.22 mmol, 5.0 eq) at ⁇ 15° C. The reaction was stirred at ⁇ 15° C. for 1 h and then allowed to warm to ambient temperature. A new solution of chloramine in diethylether (2.7% strength) was prepared as described above. Additional sodium hydride dispersion (0.20 g, 4.96mmol, 4.0 eq) and chloramine (new solution) (10.4 g, 5.46 mmol, 4.4 eq) were added and the reaction was stirred for 1 h at ambient temperature.
- the compound of formula (XIII) can be formed from the compound of formula (XVII) via step b6) as described above.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07012546A EP2008996A1 (en) | 2007-06-27 | 2007-06-27 | Process for the production of pyrazoles |
EP07012546.3 | 2007-06-27 | ||
PCT/EP2008/004830 WO2009000442A2 (en) | 2007-06-27 | 2008-06-16 | Processes for the preparation of pyrazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100256390A1 true US20100256390A1 (en) | 2010-10-07 |
Family
ID=38812166
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/665,738 Abandoned US20100256390A1 (en) | 2007-06-27 | 2008-06-16 | Processes for the preparation of pyrazoles |
US12/666,179 Active 2028-12-06 US8269020B2 (en) | 2007-06-27 | 2008-06-16 | Processes for the preparation of pyrazoles |
US13/621,686 Active US8785657B2 (en) | 2007-06-27 | 2012-09-17 | Processes for the preparation of pyrazoles |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/666,179 Active 2028-12-06 US8269020B2 (en) | 2007-06-27 | 2008-06-16 | Processes for the preparation of pyrazoles |
US13/621,686 Active US8785657B2 (en) | 2007-06-27 | 2012-09-17 | Processes for the preparation of pyrazoles |
Country Status (18)
Country | Link |
---|---|
US (3) | US20100256390A1 (pt) |
EP (3) | EP2008996A1 (pt) |
JP (2) | JP2010531315A (pt) |
KR (2) | KR20100025533A (pt) |
CN (3) | CN101687806A (pt) |
AR (2) | AR067356A1 (pt) |
AU (2) | AU2008267472A1 (pt) |
BR (2) | BRPI0813903A2 (pt) |
CA (2) | CA2689218A1 (pt) |
CL (2) | CL2008001896A1 (pt) |
CO (2) | CO6251314A2 (pt) |
CR (2) | CR11162A (pt) |
EC (2) | ECSP099818A (pt) |
IL (2) | IL202419A0 (pt) |
MX (2) | MX2009013591A (pt) |
RU (2) | RU2010102137A (pt) |
TW (2) | TW200916445A (pt) |
WO (2) | WO2009000441A1 (pt) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110009642A1 (en) * | 2008-02-25 | 2011-01-13 | Bayer Cropscience Ag | Method for the Regioselective Synthesis of 1-Alkyl-3-haloalkyl-pyrazole-4-carboxylic Acid Derivatives |
US20130237710A1 (en) * | 2008-09-30 | 2013-09-12 | Solvay Sa | Process for the synthesis of halogenated cyclic compounds |
US10239841B2 (en) | 2015-03-26 | 2019-03-26 | AGC Inc. | Method for producing pyrazole derivative |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2008996A1 (en) * | 2007-06-27 | 2008-12-31 | Syngeta Participations AG | Process for the production of pyrazoles |
GB0908435D0 (en) * | 2009-05-15 | 2009-06-24 | Syngenta Ltd | Processes |
WO2012025469A1 (en) * | 2010-08-24 | 2012-03-01 | Solvay Sa | Improved process for the preparation of esters of 1-h-pyrazole-4-carboxylic acids |
FR2975992B1 (fr) * | 2011-06-01 | 2013-11-08 | Rhodia Operations | Procede de preparation d'un compose fluoromethylpyrazole sous forme acide carboxylique ou derivee |
FR2975990B1 (fr) * | 2011-06-01 | 2013-05-24 | Rhodia Operations | Procede de preparation d'un compose organique fluore |
MX348274B (es) * | 2012-05-14 | 2017-06-02 | Bayer Cropscience Ag | Procedimiento de preparacion de cloruros de 1-alquil-3-fluoroalqui l-1h-pirazol-4-carbonilo. |
US8871947B2 (en) | 2013-02-04 | 2014-10-28 | KingChem LLC | Preparation of alkyl 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid ester |
WO2015059067A1 (de) | 2013-10-23 | 2015-04-30 | Bayer Cropscience Ag | Verfahren zur herstellung von halogenketonen |
CN103570623B (zh) * | 2013-11-12 | 2015-05-20 | 湖南化工研究院 | 一种3-(二氟甲基)-1-甲基-1h-吡唑-4-羧酸的制备方法 |
US9139507B2 (en) | 2013-12-09 | 2015-09-22 | KingChem LLC. | Process for the preparation of alkyl 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylate and its analogs |
CN103787977B (zh) * | 2014-01-21 | 2016-05-25 | 南通雅本化学有限公司 | 一种空气氧化制备3-氟代烷基-1-取代吡唑-4-羧酸的方法 |
WO2016202254A1 (zh) * | 2015-06-19 | 2016-12-22 | 浙江永太科技股份有限公司 | 一种用于制备吡唑甲酸衍生物的方法及其中间体 |
CN104945325B (zh) * | 2015-06-19 | 2017-04-05 | 浙江永太科技股份有限公司 | 一种吡唑甲酸衍生物的制备方法 |
WO2017054112A1 (zh) * | 2015-09-28 | 2017-04-06 | 常州市卜弋科研化工有限公司 | 3-氟代烷基-1-甲基吡唑-4-羧酸的制备方法 |
CN106554311B (zh) * | 2015-09-28 | 2019-03-01 | 常州市卜弋科研化工有限公司 | 3-氟代烷基-1-甲基吡唑-4-羧酸的制备方法 |
FI3797099T3 (fi) | 2018-05-21 | 2024-01-30 | Pi Industries Ltd | Menetelmä substituoitujen heterosyklisten yhdisteiden valmistamiseksi |
CN109232425A (zh) * | 2018-10-16 | 2019-01-18 | 山东省农药科学研究院 | 一种苯丙烯氟菌唑中间体3-(二氟甲基)-1-甲基-1h-吡唑-4-羧酸的合成方法 |
CN110577503A (zh) | 2019-08-02 | 2019-12-17 | 宿迁市科莱博生物化学有限公司 | 一种卤素取代化合物及其制备方法和应用 |
CN111303035A (zh) * | 2020-03-18 | 2020-06-19 | 徐州圣元化工有限公司 | 一种3-(二氟甲基)-1-甲基-1h-吡唑-4-羧酸的制备方法 |
CN111233768B (zh) * | 2020-03-18 | 2021-08-03 | 徐州圣元化工有限公司 | 一种3-(二氟甲基)-1-甲基-1h-吡唑-4-羧酸乙酯的制备方法 |
WO2022233129A1 (en) | 2021-05-05 | 2022-11-10 | Fujian Yongjing Technology Co., Ltd | New process for the synthesis of 5-fluoro-3- (difuoromethyl) -5-fluoro-1-methyl-1h-pyrazole-4-carboxylic acid derivatives and the free acid thereof |
CN114195715B (zh) * | 2021-12-31 | 2024-05-10 | 福建永晶科技股份有限公司 | 1-甲基-3-二氟甲基-4-吡唑酸和1-甲基-3-三氟甲基-4-吡唑酸的制备方法 |
CN117384096A (zh) * | 2023-12-13 | 2024-01-12 | 山东国邦药业有限公司 | 一种二氟吡唑酸的制备方法 |
CN117447401B (zh) * | 2023-12-26 | 2024-04-19 | 山东国邦药业有限公司 | 一种二氟吡唑酸的合成方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060252944A1 (en) * | 2003-10-23 | 2006-11-09 | Reinhard Lantzsch | Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl pyrazole-4-carboxylic acid esters |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0759558B2 (ja) * | 1987-12-25 | 1995-06-28 | 三井東圧化学株式会社 | 1,3−ジアルキルピラゾール−4−アルデヒド類の製造法 |
JPH0759557B2 (ja) * | 1987-12-25 | 1995-06-28 | 三井東圧化学株式会社 | 1,3−ジアルキルピラゾール−4−アルデヒド誘導体の製造方法 |
JPH089599B2 (ja) * | 1988-08-02 | 1996-01-31 | 三井東圧化学株式会社 | ピラゾールカルボン酸類の製造方法 |
AU2003295041A1 (en) * | 2002-11-20 | 2004-06-18 | L'oreal | Composition for hair care or eyelashes containing a pyrazol-carboxamide, its use for stimulating hair and eyelash growth and/or for preventing loss thereof |
EP1735302B1 (en) * | 2004-02-27 | 2010-06-16 | Eli Lilly And Company | 4-amino-piperidine derivatives as monoamine uptake inhibitors |
EP1761498A1 (de) * | 2004-06-18 | 2007-03-14 | Basf Aktiengesellschaft | 1-methyl-3-difluormethyl-pyrazol-4-carbonsäure-(ortho-phenyl)-anilide und ihre verwendung als fungizid |
SI1781662T1 (sl) * | 2004-08-18 | 2011-07-29 | Pfizer | Zaviralci RNA-odvisne RNA-polimeraze hepatitisa C in sestavki in zdravljenja, v katerih se uporabljajo |
EP1854788B8 (en) * | 2005-02-25 | 2012-12-26 | Sagami Chemical Research Institute | Method for producing 1-substituted-3-fluoroalkyl pyrazole-4-carboxylate |
CN101962363A (zh) * | 2005-09-16 | 2011-02-02 | 先正达参股股份有限公司 | 酰胺的制备方法 |
AR066802A1 (es) * | 2007-06-01 | 2009-09-16 | Basf Se | Procedimiento para la preparacion de (3-dihalometil-1-metil- pirazol-4-il) carboxamidas n-susttituidas |
EP2008996A1 (en) * | 2007-06-27 | 2008-12-31 | Syngeta Participations AG | Process for the production of pyrazoles |
-
2007
- 2007-06-27 EP EP07012546A patent/EP2008996A1/en not_active Ceased
-
2008
- 2008-06-16 CN CN200880022057A patent/CN101687806A/zh active Pending
- 2008-06-16 BR BRPI0813903-2A2A patent/BRPI0813903A2/pt not_active Application Discontinuation
- 2008-06-16 CA CA002689218A patent/CA2689218A1/en not_active Abandoned
- 2008-06-16 RU RU2010102137/04A patent/RU2010102137A/ru not_active Application Discontinuation
- 2008-06-16 EP EP08773461A patent/EP2167461B1/en active Active
- 2008-06-16 AU AU2008267472A patent/AU2008267472A1/en not_active Abandoned
- 2008-06-16 BR BRPI0813284-4A patent/BRPI0813284B1/pt active IP Right Grant
- 2008-06-16 MX MX2009013591A patent/MX2009013591A/es active IP Right Grant
- 2008-06-16 KR KR1020097026870A patent/KR20100025533A/ko not_active Application Discontinuation
- 2008-06-16 KR KR1020097026780A patent/KR20100025531A/ko not_active Application Discontinuation
- 2008-06-16 MX MX2009013592A patent/MX2009013592A/es not_active Application Discontinuation
- 2008-06-16 CN CN2011103836384A patent/CN102516175A/zh active Pending
- 2008-06-16 WO PCT/EP2008/004829 patent/WO2009000441A1/en active Application Filing
- 2008-06-16 AU AU2008267473A patent/AU2008267473A1/en not_active Abandoned
- 2008-06-16 WO PCT/EP2008/004830 patent/WO2009000442A2/en active Application Filing
- 2008-06-16 RU RU2010102135/04A patent/RU2010102135A/ru not_active Application Discontinuation
- 2008-06-16 JP JP2010513718A patent/JP2010531315A/ja active Pending
- 2008-06-16 JP JP2010513717A patent/JP5563449B2/ja active Active
- 2008-06-16 CA CA2690246A patent/CA2690246A1/en not_active Abandoned
- 2008-06-16 US US12/665,738 patent/US20100256390A1/en not_active Abandoned
- 2008-06-16 CN CN200880021857A patent/CN101796021A/zh active Pending
- 2008-06-16 EP EP08773462A patent/EP2170832A2/en not_active Withdrawn
- 2008-06-16 US US12/666,179 patent/US8269020B2/en active Active
- 2008-06-23 TW TW097123281A patent/TW200916445A/zh unknown
- 2008-06-23 TW TW097123280A patent/TW200914428A/zh unknown
- 2008-06-26 CL CL2008001896A patent/CL2008001896A1/es unknown
- 2008-06-26 CL CL2008001897A patent/CL2008001897A1/es unknown
- 2008-06-27 AR ARP080102805A patent/AR067356A1/es not_active Application Discontinuation
- 2008-06-27 AR ARP080102804A patent/AR067355A1/es not_active Application Discontinuation
-
2009
- 2009-11-30 IL IL202419A patent/IL202419A0/en unknown
- 2009-12-10 IL IL202664A patent/IL202664A/en active IP Right Grant
- 2009-12-14 CR CR11162A patent/CR11162A/es not_active Application Discontinuation
- 2009-12-14 CO CO09142556A patent/CO6251314A2/es not_active Application Discontinuation
- 2009-12-14 CO CO09142558A patent/CO6251313A2/es not_active Application Discontinuation
- 2009-12-14 CR CR11161A patent/CR11161A/es not_active Application Discontinuation
- 2009-12-18 EC EC2009009818A patent/ECSP099818A/es unknown
- 2009-12-18 EC EC2009009817A patent/ECSP099817A/es unknown
-
2012
- 2012-09-17 US US13/621,686 patent/US8785657B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060252944A1 (en) * | 2003-10-23 | 2006-11-09 | Reinhard Lantzsch | Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl pyrazole-4-carboxylic acid esters |
Non-Patent Citations (1)
Title |
---|
Braibante et al. Journal of Heterocyclic Chemistry (1993), 30(4), 1159-60 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110009642A1 (en) * | 2008-02-25 | 2011-01-13 | Bayer Cropscience Ag | Method for the Regioselective Synthesis of 1-Alkyl-3-haloalkyl-pyrazole-4-carboxylic Acid Derivatives |
US8629288B2 (en) * | 2008-02-25 | 2014-01-14 | Bayer Intellectual Property Gmbh | Method for the regioselective synthesis of 1-alky1-3-haloalkyl-pyrazole-4-carboxylic acid derivatives |
US20130237710A1 (en) * | 2008-09-30 | 2013-09-12 | Solvay Sa | Process for the synthesis of halogenated cyclic compounds |
US8981115B2 (en) * | 2008-09-30 | 2015-03-17 | Solvay Sa | Process for the synthesis of halogenated cyclic compounds |
US10239841B2 (en) | 2015-03-26 | 2019-03-26 | AGC Inc. | Method for producing pyrazole derivative |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100256390A1 (en) | Processes for the preparation of pyrazoles | |
US7863460B2 (en) | Process for producing 1-substituted-3-fluoroalkylpyrazole-4-carboxylate | |
US20060252944A1 (en) | Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl pyrazole-4-carboxylic acid esters | |
US10457645B2 (en) | Method for the preparation of 3-fluoroalkyl-1-methylpyrazol-4-carboxylic acid | |
US8822716B2 (en) | Intermediate of cilastatin and preparation method thereof | |
US7585998B2 (en) | Method for producing difluoro-acetyl-acetic acid alkylesters | |
US9145369B2 (en) | Process for preparing 1-alkyl-3-fluoroalkyl-1H-pyrazole-4-carboxylic acid chlorides | |
US20040171886A1 (en) | Method for producing 2- (alkyl) cycloalkenone | |
JP4407896B2 (ja) | 2−(アルキル)シクロアルケノンの製法 | |
WO2018180943A1 (ja) | ハロゲン含有ピラゾールカルボン酸及びその中間体の製造方法 | |
CN107428648B (zh) | 用于制备可用于合成美托咪定的诸如3-芳基丁醛的化合物的方法 | |
NO179100B (no) | Fremgangsmåte for fremstilling av trifluoracetaldehyd | |
JP4609610B2 (ja) | 4−メチルピラゾール−5−カルボン酸化合物の製造方法 | |
US10273200B2 (en) | Practical method for manufacturing 3,3-difluoro-2-hydroxypropionic acid | |
HU204792B (en) | Process for producing 1-aryl-5-aminopyrazole derivatives | |
JPH06166666A (ja) | ヒドラゾン誘導体およびその製造方法 | |
JP2008297234A (ja) | ブロモテトラフルオロアルカノール類の製造方法 | |
JPH11228485A (ja) | 3,3−ジメチル酪酸の製造方法 | |
JPH0361657B2 (pt) | ||
JPH06340630A (ja) | 2−クロロ−ピリジンメタノールの製造方法 | |
JPH10265433A (ja) | フェニルプロピオン酸誘導体の製造法 | |
JPS63287741A (ja) | β−フルオロアシル−β−ハロビニルアルキルエーテル | |
JP4105198B2 (ja) | 1,1−シクロプロパンジメタノールの製造方法 | |
EP0003066A2 (en) | Process for the preparation of meta-aryloxybenzaldehydes, and meta- aryloxybenzaldehydes produced by the process | |
JPH0753456A (ja) | 1−フルオロ−2−オキソシクロアルカンカルボン酸誘導体及びその塩 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |